Meeting
2020 ASCO Virtual Scientific Program
Mutation of DNA damage repair genes confers an immune-privileged tumor microenvironment in colorectal cancer with a prognostic value.
Authors
Dandan Liang
Genecast Precision Medicine Technology Institute, Beijing, China
Dandan Liang , Huan Chen , Ying Yang , Guanxiong Zhang , Jiao Zhang , Henghui Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4080)
DOI
10.1200/JCO.2020.38.15_suppl.4080
Abstract #
4080
Poster Bd #
72
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers.
First Author: Fiyinfolu Balogun
Poster
2022 ASCO Annual Meeting
Comparative analysis of microsatellite instability-high (MSI-H) BRAF V600E-mutated versus MSI-H BRAF wild type colorectal cancers (CRC), including tumor microenvironment (TME), associated genomic alterations, and immunometabolomic biomarkers.
First Author: Mohamed E. Salem
Poster
2024 ASCO Gastrointestinal Cancers Symposium
POLE variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).
First Author: Rachel Beth Keller
Poster
2023 ASCO Annual Meeting
Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.
First Author: Claire Gallois